New research may lead to cure for type 1 diabetesDay Greenberg
BEIJING, Sept. 26 (Xinhua) -- Chinese scientists have realized the clinical cure of a type 1 diabetes patient by transplanting islet cells derived from chemically induced pluripotent stem cells (CiPSC-islets), according to clinical research published on Wednesday in the journal Cell. This CiPSC-...
Johnson & Johnson, continuing its long quest for a Type 1 diabetes cure, is joining forces with biotech company ViaCyte to speed development of the first stem cell treatment that could fix the life-threatening hormonal disorder. They've already begun testing it in a small number of diab...
In 2017 researchers kicked off a Phase 1/2 human clinical trial testing an experimental implant designed to replace the missing insulin cells in type 1 diabetics. The device has been described as a “functional cure” for type 1 diabetes. This means it isn’t a direc...
The expected cost for a Betalin biological pancreas is $50,000 which is hardly an affordable cure for the general population of those with type 1 diabetes. But one could hope the price would fall quickly if they do make it past FDA-approval and into the medical technology market. ...
This five-year study was a national effort to identify the number of children and youth under the age of 20 who have diabetes, both Type 1 and Type 2, and to provide the opportunity to learn more about the disease, its complications and its effects on the everyday lives of those who ...
These devices have such a high degree of potential that they are, at times, mentioned as a virtual cure for the disease鈥攁 first for technology in this space. As such, these devices will undoubtedly alter the research landscape in a field that has predominantly been occupied by ...
- 《Journal of Diabetes Research》 被引量: 17发表: 2014年 PD-L1-driven tolerance protects neurogenin3-induced islet neogenesis to reverse established type 1 diabetes in NOD mice. A breakdown in self-tolerance underlies autoimmune destruction of 尾-cells and type 1 diabetes. A cure by restoring...
Following the seminal discovery of insulin a century ago, treatment of individuals with type 1 diabetes (T1D) has been largely restricted to efforts to monitor and treat metabolic glucose dysregulation. The recent regulatory approval of the first immunot
As Fàtima Bosch, the head researcher, points out, "this study is the first to demonstrate a long-term cure for diabetes in a largeanimal modelusing gene therapy." This same research group had already tested this type of therapy on mice, but the excellent results obtained for the first tim...